Login to Your Account

Financings Roundup

Anadys Raises $62M To Advance Early Programs

By Karen Pihl-Carey

Monday, August 8, 2005
Two months ago, when Anadys Pharmaceuticals Inc. signed what might be the largest Phase I deal in biotech history, the company's CEO said Anadys wouldn't need to do a financing for at least two years. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription